【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 20
2 Introduction 21
2.1 Respiratory Devices Overview 21
3 Products under Development 24
3.1 Respiratory Devices – Pipeline Products by Stage of Development 24
3.2 Respiratory Devices – Pipeline Products by Segment 25
3.3 Respiratory Devices – Pipeline Products by Territory 27
3.4 Respiratory Devices – Pipeline Products by Regulatory Path 29
3.5 Respiratory Devices – Pipeline Products by Estimated Approval Date 31
3.6 Respiratory Devices – Ongoing Clinical Trials 32
4 Respiratory Devices – Pipeline Products under Development by Companies 33
4.1 Respiratory Devices Companies – Pipeline Products by Stage of Development 33
4.2 Respiratory Devices – Pipeline Products by Stage of Development 38
5 Respiratory Devices Companies and Product Overview 43
5.1 Ablynx NV Company Overview 43
5.1.1 Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 43
5.2 Advanced Brain Monitoring, Inc. Company Overview 45
5.2.1 Advanced Brain Monitoring, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.3 Advanced Circulatory Systems, Inc. Company Overview 46
5.3.1 Advanced Circulatory Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.4 Afalapi Company Overview 48
5.4.1 Afalapi Pipeline Products & Ongoing Clinical Trials Overview 48
5.5 Airing LLC Company Overview 49
5.5.1 Airing LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.6 Alaxo GmbH Company Overview 50
5.6.1 Alaxo GmbH Pipeline Products & Ongoing Clinical Trials Overview 50
5.7 Aloro Medical AB Company Overview 53
5.7.1 Aloro Medical AB Pipeline Products & Ongoing Clinical Trials Overview 53
5.8 ALung Technologies, Inc. Company Overview 54
5.8.1 ALung Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.9 Anaxsys Technology Ltd Company Overview 60
5.9.1 Anaxsys Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
5.10 Baby’s Breath Ltd. Company Overview 61
5.10.1 Baby’s Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview 61
5.11 Beijing Dehaier Medical Technology Co., Ltd. Company Overview 62
5.11.1 Beijing Dehaier Medical Technology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 62
5.12 Blucore Pty Ltd Company Overview 69
5.12.1 Blucore Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
5.13 Broncus Medical, Inc. Company Overview 70
5.13.1 Broncus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.14 Cambridge Consultants Limited Company Overview 73
5.14.1 Cambridge Consultants Limited Pipeline Products & Ongoing Clinical Trials Overview 73
5.15 Capnia, Inc. Company Overview 74
5.15.1 Capnia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.16 Case Western Reserve University Company Overview 75
5.16.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 75
5.17 Circadiance LLC Company Overview 76
5.17.1 Circadiance LLC Pipeline Products & Ongoing Clinical Trials Overview 76
5.18 Cleveland Medical Devices, Inc. Company Overview 77
5.18.1 Cleveland Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.19 Columbia Life Systems, Inc. Company Overview 78
5.19.1 Columbia Life Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.20 Creare Inc. Company Overview 79
5.20.1 Creare Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.21 Deca-Medics, Inc. Company Overview 80
5.21.1 Deca-Medics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.22 DesignWise Medical Inc. Company Overview 81
5.22.1 DesignWise Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.23 Discover Medical Device Ltd. Company Overview 83
5.23.1 Discover Medical Device Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83
5.24 Endoclear LLC Company Overview 85
5.24.1 Endoclear LLC Pipeline Products & Ongoing Clinical Trials Overview 85
5.25 Exploit Technologies Pte Ltd Company Overview 86
5.25.1 Exploit Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 86
5.26 Filtara, Inc. Company Overview 88
5.26.1 Filtara, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.27 Fisher & Paykel Healthcare Corporation Limited Company Overview 89
5.27.1 Fisher & Paykel Healthcare Corporation Limited Pipeline Products & Ongoing Clinical Trials Overview 89
5.28 GE Healthcare Company Overview 93
5.28.1 GE Healthcare Pipeline Products & Ongoing Clinical Trials Overview 93
5.29 GeNO, LLC Company Overview 94
5.29.1 GeNO, LLC Pipeline Products & Ongoing Clinical Trials Overview 94
5.30 Haemair Limited Company Overview 97
5.30.1 Haemair Limited Pipeline Products & Ongoing Clinical Trials Overview 97
5.31 Hamilton Medical AG Company Overview 99
5.31.1 Hamilton Medical AG Pipeline Products & Ongoing Clinical Trials Overview 99
5.32 Holaira, Inc. Company Overview 103
5.32.1 Holaira, Inc. Pipeline Products & Ongoing Clinical Trials Overview 103
5.33 INCA Medical Systems Ltd Company Overview 106
5.33.1 INCA Medical Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview 106
5.34 Innovent Medical Solutions, Ltd. Company Overview 109
5.34.1 Innovent Medical Solutions, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 109
5.35 Inogen, Inc. Company Overview 112
5.35.1 Inogen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 112
5.36 inSleep Health Company Overview 114
5.36.1 inSleep Health Pipeline Products & Ongoing Clinical Trials Overview 114
5.37 IntelliBreathe Ltd. Company Overview 115
5.37.1 IntelliBreathe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 115
5.38 iSonea (Israel) Limited Company Overview 116
5.38.1 iSonea (Israel) Limited Pipeline Products & Ongoing Clinical Trials Overview 116
5.39 Lehigh University Company Overview 125
5.39.1 Lehigh University Pipeline Products & Ongoing Clinical Trials Overview 125
5.40 Liberate Medical, LLC Company Overview 126
5.40.1 Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 126
5.41 LifeServe Innovations, LLC Company Overview 130
5.41.1 LifeServe Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 130
5.42 Lingua Flex, LLC Company Overview 135
5.42.1 Lingua Flex, LLC Pipeline Products & Ongoing Clinical Trials Overview 135
5.43 Lungpacer Medical Inc. Company Overview 136
5.43.1 Lungpacer Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.44 Marquette University Company Overview 139
5.44.1 Marquette University Pipeline Products & Ongoing Clinical Trials Overview 139
5.45 Massachusetts Institute of Technology Company Overview 140
5.45.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 140
5.46 McGowan Institute for Regenerative Medicine Company Overview 141
5.46.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 141
5.47 Medical Developments International Limited Company Overview 145
5.47.1 Medical Developments International Limited Pipeline Products & Ongoing Clinical Trials Overview 145
5.48 Medivations Pty Ltd Company Overview 148
5.48.1 Medivations Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 148
5.49 Mergenet Medical, Inc. Company Overview 149
5.49.1 Mergenet Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.50 Michigan Critical Care Consultants, Inc. Company Overview 150
5.50.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.51 Miromatrix Medical Inc. Company Overview 152
5.51.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
5.52 New Air, Inc. Company Overview 153
5.52.1 New Air, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.53 NightBalance B.V. Company Overview 154
5.53.1 NightBalance B.V. Pipeline Products & Ongoing Clinical Trials Overview 154
5.54 Northwestern University Company Overview 155
5.54.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 155
5.55 Noveko International Inc. Company Overview 156
5.55.1 Noveko International Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.56 Nu-Med Plus, Inc. Company Overview 159
5.56.1 Nu-Med Plus, Inc. Pipeline Products & Ongoing Clinical Trials Overview 159
5.57 OneBreath Inc. Company Overview 161
5.57.1 OneBreath Inc. Pipeline Products & Ongoing Clinical Trials Overview 161
5.58 PARI Pharma GmbH Company Overview 162
5.58.1 PARI Pharma GmbH Pipeline Products & Ongoing Clinical Trials Overview 162
5.59 Pavad Medical Company Overview 164
5.59.1 Pavad Medical Pipeline Products & Ongoing Clinical Trials Overview 164
5.60 Pharmagenix AG Company Overview 165
5.60.1 Pharmagenix AG Pipeline Products & Ongoing Clinical Trials Overview 165
5.61 Philips Healthcare Company Overview 166
5.61.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 166
5.62 Pneumedicare Ltd. Company Overview 169
5.62.1 Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview 169
5.63 Portaero Company Overview 170
5.63.1 Portaero Pipeline Products & Ongoing Clinical Trials Overview 170
5.64 Pulmonx Corporation Company Overview 173
5.64.1 Pulmonx Corporation Pipeline Products & Ongoing Clinical Trials Overview 173
5.65 Reactive Innovations, LLC Company Overview 182
5.65.1 Reactive Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 182
5.66 Respicardia, Inc. Company Overview 183
5.66.1 Respicardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 183
5.67 RespiNova Ltd. Company Overview 186
5.67.1 RespiNova Ltd. Pipeline Products & Ongoing Clinical Trials Overview 186
5.68 Respiratory Research, Inc. Company Overview 187
5.68.1 Respiratory Research, Inc. Pipeline Products & Ongoing Clinical Trials Overview 187
5.69 Rhinomed Limited Company Overview 189
5.69.1 Rhinomed Limited Pipeline Products & Ongoing Clinical Trials Overview 189
5.70 Rice University Company Overview 192
5.70.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 192
5.71 Rox Medical, Inc. Company Overview 196
5.71.1 Rox Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.72 Sleep Secure LLC Company Overview 199
5.72.1 Sleep Secure LLC Pipeline Products & Ongoing Clinical Trials Overview 199
5.73 SleepUp Ltd. Company Overview 200
5.73.1 SleepUp Ltd. Pipeline Products & Ongoing Clinical Trials Overview 200
5.74 Smart Oxygen Solutions, Inc. Company Overview 202
5.74.1 Smart Oxygen Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 202
5.75 SolAeroMed Inc. Company Overview 203
5.75.1 SolAeroMed Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.76 Spiration, Inc. Company Overview 204
5.76.1 Spiration, Inc. Pipeline Products & Ongoing Clinical Trials Overview 204
5.77 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 210
5.77.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 210
5.78 Stanford University Company Overview 211
5.78.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 211
5.79 Stirling Pharma Inc Company Overview 213
5.79.1 Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 213
5.80 Tda Research Inc. Company Overview 214
5.80.1 Tda Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 214
5.81 Tenax Therapeutics, Inc. (Inactive) Company Overview 215
5.81.1 Tenax Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 215
5.82 The Charles Stark Draper Laboratory Inc Company Overview 217
5.82.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 217
5.83 The Johns Hopkins University Company Overview 219
5.83.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 219
5.84 The University of Melbourne Company Overview 222
5.84.1 The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 222
5.85 TigerLAB Company Overview 223
5.85.1 TigerLAB Pipeline Products & Ongoing Clinical Trials Overview 223
5.86 United Hayek Industries Inc. Company Overview 224
5.86.1 United Hayek Industries Inc. Pipeline Products & Ongoing Clinical Trials Overview 224
5.87 United Therapeutics Corporation Company Overview 225
5.87.1 United Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview 225
5.88 Universitatsklinikum Freiburg Company Overview 227
5.88.1 Universitatsklinikum Freiburg Pipeline Products & Ongoing Clinical Trials Overview 227
5.89 University of California, Los Angeles Company Overview 230
5.89.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 230
5.90 University of California, San Diego Company Overview 233
5.90.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 233
5.91 University of California, San Francisco Company Overview 235
5.91.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 235
5.92 University of Kansas Company Overview 241
5.92.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 241
5.93 University of Maryland, Baltimore Company Overview 243
5.93.1 University of Maryland, Baltimore Pipeline Products & Ongoing Clinical Trials Overview 243
5.94 University of Michigan Pediatric Device Consortium Company Overview 244
5.94.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 244
5.95 University of Missouri Company Overview 249
5.95.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 249
5.96 University of Pittsburgh Company Overview 251
5.96.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 251
5.97 University of Rochester Company Overview 253
5.97.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 253
5.98 University of Texas Medical Branch at Galveston Company Overview 254
5.98.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 254
5.99 Vivonics, Inc. Company Overview 256
5.99.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 256
5.100 Wet Nose Technologies, LLC Company Overview 257
5.100.1 Wet Nose Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 257
5.101 Windmill Health Technologies Private Limited Company Overview 258
5.101.1 Windmill Health Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 258
5.102 Wyngate Medical Technologies, Inc. Company Overview 259
5.102.1 Wyngate Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 259
5.103 Xenios AG Company Overview 260
5.103.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 260
5.104 Xo Thermix Medical, Inc Company Overview 262
5.104.1 Xo Thermix Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 262
5.105 Z-Cube S.r.l. Company Overview 263
5.105.1 Z-Cube S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 263
5.106 Zoll Medical Corporation Company Overview 264
5.106.1 Zoll Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 264
6 Respiratory Devices- Recent Developments 266
7 Appendix 456
7.1 Methodology 456
7.2 About GlobalData 458
7.3 Contact Us 459
7.4 Disclaimer 459
【レポート販売概要】
■ タイトル：世界の呼吸装置開発動向：医療機器パイプライン分析2015■ 英文：Respiratory Devices - Medical Devices Pipeline Assessment, 2015
■ 発行日：2016年1月5日
■ 調査会社：GlobalData
■ 商品コード：GDME0144EPD
■ 調査対象地域：グローバル
- 世界のD-ダイマー検査市場The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and D-Dimer testing specifically, will become more standardized, offering opp …
- 世界の装甲車両市場動向と予測2014-2019The report provides an in depth analysis of the present industry size and growth prospects during the forecast period, including highlights of key growth stimulators. The report further benchmarks the industry against key global markets and provides detailed understanding of emerging opportunities in specific areas. The report further scrutinizes the market for armored vehicles used in defense, ho …
- アイウェアの世界市場：眼鏡、サングラス、コンタクトレンズAbout the Eyewear Market The global eyewear market is driven by the high prevalence of eyesight disorders and increase in demand for discretionary eyewear. Approximately 75% of the population in APAC and 35% in Europe have some form of myopia or hyperopia. Changing dietary habits and increased amounts of time spent playing video games, watching television, and in front of computers at work can aff …
- メチル第三ブチル・エーテル(MTBE)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world methyl tertiary butyl ether market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together g …
- Crocotta Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Crocotta Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Crocotta Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 世界のコーティング添加剤市場Coating additives are specially engineered and developed materials, witnessing growth in market demand. This growth is driven by the end-user segments where they are being used extensively owing to their ability to improve the performance of the coating chemically, and make it visually appealing. Coating additives contribute towards the improvement of factors that affect the performance of coating …
- ハイブリッド商用車の世界市場2016-2020About Hybrid Commercial Vehicle Commercial vehicles are defined as vehicles that are over 8,500 lb. in gross weight. These vehicles include heavy trucks and light commercial vehicles (LCVs), such as pickup trucks and vans. Internal combustion engines (ICE) propel most conventional commercial vehicles. However, recent emphasis on preserving the environment coupled with the need to explore and promo …
- プレストレスト・コンクリート（PC）ワイヤ＆ストランドの世界市場ABSTRACTAbout Prestressed Concrete (PC) Wire and Strand The artificial compression stress applied to neutralize tensile stress deployed by exterior force is known as prestress. The structures constructed with prestress is called PC. The wire or strand used on PC structure is known as PC wire or strand. When force is applied to the concrete, prestressing is introduced to counter the stresses result …
- 糖尿病性末梢神経障害(Diabetic Peripheral Neuropathy)の治療薬パイプライン動向（2015年上半期版）Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Peripheral Neuropathy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stage …
- 機内エンターテインメント（IFE）の世界市場予測（～2022）The inflight entertainment (IFE) market is projected to grow from an estimated USD 3.18 Billion in 2016 to USD 6.91 Billion by 2022, at a CAGR of 13.80% during the forecast period. Enhancing passenger experience, new technology development, and major source of ancillary revenue for airlines through inflight entertainment (IFE) are key factors expected to drive the inflight entertainment (IFE) mark …
- 世界のインシュリン市場（～2019）The expansion of the global insulin industry is forecast to reach 9.0% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 11.2%. Currently, dosage insulin accounts for 89.3% of the global demand while bulk insulin has a 10.7% share of the market. China, France, Germany, Japan and the United States represent the largest insulin markets while the st …
- 世界のウェアラブル医療技術市場動向（2012-2016）TechNavio's analysts forecast the Global Wearable Medical Technology market to grow at a CAGR of 49.94 percent over the period 2012-2016. One of the key factors contributing to this market growth is the technological innovations. The Global Wearable Medical Technology market has also been witnessing increasing strategic agreements among vendors. However, the instances of product recalls could pose …
- ネットワーク分析ソリューションの世界市場2016-2020About the Network Analytics Market Network analytics solutions enable network supervisors to understand, visualize, and record activities occurring on the networks. These solutions focus on network and equipment behavior. Network analytics solutions help mobile network operators identify network problems ahead of time. Network operators can also improve their customer strategies and experience wit …
- パーソナルファイナンスソフトウェアのアメリカ市場The U.S. personal finance software market size was valued at $232 million in 2018, and is expected to reach $343 million by 2026, registering a CAGR of 5% from 2019 to 2026. Personal finance software is a tool designed to integrate the financial data of a user and segregate this information to deliver a desired analytical output for improved financial planning. This software tool utilizes a variet …
- Endeavour International Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Endeavour International Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The r …
